These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34901391)

  • 1. Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment.
    Shi G; Shi P; Yu Y; Xu J; Ma J; Zhang Y; Dong Z; Shen L; Dai L; Cheng L; Cheng P; Deng H
    Mol Ther Oncolytics; 2021 Dec; 23():488-500. PubMed ID: 34901391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulating the Tumor Microenvironment via Oncolytic Viruses and CSF-1R Inhibition Synergistically Enhances Anti-PD-1 Immunotherapy.
    Shi G; Yang Q; Zhang Y; Jiang Q; Lin Y; Yang S; Wang H; Cheng L; Zhang X; Li Y; Wang Q; Liu Y; Wang Q; Zhang H; Su X; Dai L; Liu L; Zhang S; Li J; Li Z; Yang Y; Yu D; Wei Y; Deng H
    Mol Ther; 2019 Jan; 27(1):244-260. PubMed ID: 30527756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of multiple immune checkpoint molecules on T cells in malignant ascites from epithelial ovarian carcinoma.
    Imai Y; Hasegawa K; Matsushita H; Fujieda N; Sato S; Miyagi E; Kakimi K; Fujiwara K
    Oncol Lett; 2018 May; 15(5):6457-6468. PubMed ID: 29616115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel oncolytic virus induces a regional cytokine storm and safely eliminates malignant ascites of colon cancer.
    Dong S; Liu B; Hu S; Guo F; Zhong Y; Cai Q; Zhang S; Qian Y; Wang J; Zhou F
    Cancer Med; 2022 Nov; 11(22):4297-4309. PubMed ID: 35510373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colony-stimulating factor-1 receptor inhibition combined with paclitaxel exerts effective antitumor effects in the treatment of ovarian cancer.
    Yu M; Wu Y; Li Q; Hong W; Yang Y; Hu X; Yang Y; Lu T; Zhao X; Wei X
    Genes Dis; 2024 May; 11(3):100989. PubMed ID: 38303927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased canonical NF-kappaB signaling specifically in macrophages is sufficient to limit tumor progression in syngeneic murine models of ovarian cancer.
    Hoover AA; Hufnagel DH; Harris W; Bullock K; Glass EB; Liu E; Barham W; Crispens MA; Khabele D; Giorgio TD; Wilson AJ; Yull FE
    BMC Cancer; 2020 Oct; 20(1):970. PubMed ID: 33028251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer.
    Lee YS; Lee WS; Kim CW; Lee SJ; Yang H; Kong SJ; Ning J; Yang KM; Kang B; Kim WR; Chon HJ; Kim C
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33199510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer.
    Yan S; Fang J; Chen Y; Xie Y; Zhang S; Zhu X; Fang F
    BMC Cancer; 2020 Dec; 20(1):1205. PubMed ID: 33287740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological changes in the ascites of cancer patients after intraperitoneal administration of the bispecific antibody catumaxomab (anti-EpCAM×anti-CD3).
    Fossati M; Buzzonetti A; Monego G; Catzola V; Scambia G; Fattorossi A; Battaglia A
    Gynecol Oncol; 2015 Aug; 138(2):343-51. PubMed ID: 26049121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity.
    Santos JM; Heiniö C; Cervera-Carrascon V; Quixabeira DCA; Siurala M; Havunen R; Butzow R; Zafar S; de Gruijl T; Lassus H; Kanerva A; Hemminki A
    J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31940588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression.
    Rowswell-Turner RB; Singh RK; Urh A; Yano N; Kim KK; Khazan N; Pandita R; Sivagnanalingam U; Hovanesian V; James NE; Ribeiro JR; Kadambi S; Linehan DC; Moore RG
    J Immunol; 2021 May; 206(10):2478-2488. PubMed ID: 33903172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response.
    Zhang Y; Qian L; Chen K; Gu S; Wang J; Meng Z; Li Y; Wang P
    Mol Ther Oncolytics; 2022 Jun; 25():31-42. PubMed ID: 35399603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells.
    Carmi YK; Agbarya A; Khamaisi H; Farah R; Shechtman Y; Korobochka R; Gopas J; Mahajna J
    Transl Oncol; 2024 Jun; 44():101939. PubMed ID: 38489872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer.
    Minott JA; van Vloten JP; Yates JGE; Santry LA; Matuszewska K; Pereira M; Goens MM; Viloria-Petit AM; Wood GA; Karimi K; Petrik JJ; Bridle BW; Wootton SK
    Mol Ther Oncolytics; 2023 Dec; 31():100748. PubMed ID: 38075247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer.
    Kim S; Lee M; Dhanasekaran DN; Song YS
    BMC Cancer; 2018 Dec; 18(1):1232. PubMed ID: 30526541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma.
    Ao JY; Zhu XD; Chai ZT; Cai H; Zhang YY; Zhang KZ; Kong LQ; Zhang N; Ye BG; Ma DN; Sun HC
    Mol Cancer Ther; 2017 Aug; 16(8):1544-1554. PubMed ID: 28572167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocyte-associated protein 4 antibody aggrandizes antitumor immune response of oncolytic virus M1 via targeting regulatory T cells.
    Liu W; Liu Y; Hu C; Xu C; Chen J; Chen Y; Cai J; Yan G; Zhu W
    Int J Cancer; 2021 Sep; 149(6):1369-1384. PubMed ID: 34086978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Immune-Related Key Genes in Ovarian Cancer Based on WGCNA.
    Quan Q; Xiong X; Wu S; Yu M
    Front Genet; 2021; 12():760225. PubMed ID: 34868239
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.